JBS N.V. (JBS)
Every figure this model derived for JBS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 2,099,269,000 | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
2025-12-31 |
| cash | 4,565,136,000 | CashAndCashEquivalents |
2025-12-31 |
| current assets | 18,438,203,000 | CurrentAssets |
2025-12-31 |
| current liabilities | 11,541,810,000 | CurrentLiabilities |
2025-12-31 |
| equity | 8,703,580,000 | EquityAttributableToOwnersOfParent |
2025-12-31 |
| interest expense | 1,677,957,000 | InterestExpense |
2025-12-31 |
| ocf | 2,931,953,000 | CashFlowsFromUsedInOperatingActivities |
2025-12-31 |
| revenue | 86,184,182,000 | Revenue |
2025-12-31 |
| sbc | 28,851,000 | AdjustmentsForSharebasedPayments |
2025-12-31 |
The ratios
The figures themselves rather than their scores — what somebody looking up JBS on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 7.54 |
| current ratio | 1.65 |
| current ratio reported | 1.6 |
| deferred revenue growth | 26.06 |
| dilution pct | 0.0 |
| ebit cagr | 95.79 |
| ebit yoy | -4.98 |
| ev ebit | 3.01 |
| ev owner earnings | 15.56 |
| ev sales | 0.15 |
| fcf margin | 0.97 |
| interest cover | 2.48 |
| operating margin | 4.83 |
| owner earnings margin | 0.93 |
| revenue growth | 11.66 |
| revenue growth per share | 11.66 |
| roic | 47.42 |
| rule of 40 | 16.49 |
| sbc pct revenue | 0.03 |
Everything else this filing tags
278 more elements from JBS's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.
| Element | Newest | As of | Periods | Unit |
|---|---|---|---|---|
OtherRevenue | 86,184,182,000 | 2025-12-31 | 7 | USD |
CostOfSales | 74,884,902,000 | 2025-12-31 | 7 | USD |
Assets | 45,156,486,000 | 2025-12-31 | 4 | USD |
EquityAndLiabilities | 45,156,486,000 | 2025-12-31 | 4 | USD |
OtherAssets | 45,156,486,000 | 2025-12-31 | 5 | USD |
FinancialLiabilities | -30,652,191,000 | 2025-12-31 | 4 | USD |
PurchaseOfBiologicalAssets | 27,900,000,000 | 2025-12-31 | 4 | USD |
NoncurrentAssets | 26,718,283,000 | 2025-12-31 | 4 | USD |
LiabilitiesArisingFromFinancingActivities | -25,120,029,000 | 2025-12-31 | 4 | USD |
NoncurrentLiabilities | 24,091,885,000 | 2025-12-31 | 4 | USD |
PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets | 23,676,865,000 | 2025-12-31 | 1 | USD |
LoansAndAdvancesToBanks | 21,090,568,000 | 2025-12-31 | 4 | USD |
LongtermBorrowings | 20,257,483,000 | 2025-12-31 | 4 | USD |
FinancialAssetsAtFairValue | 18,157,182,000 | 2025-12-31 | 4 | USD |
PropertyPlantAndEquipment | 13,645,658,000 | 2025-12-31 | 8 | USD |
PropertyPlantAndEquipmentExpendituresRecognisedForConstructions | 13,645,658,000 | 2025-12-31 | 2 | USD |
GrossProfit | 11,299,280,000 | 2025-12-31 | 7 | USD |
ProceedsFromBorrowingsClassifiedAsFinancingActivities | 10,087,277,000 | 2025-12-31 | 5 | USD |
DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets | 10,031,207,000 | 2025-12-31 | 1 | USD |
Equity | 9,522,791,000 | 2025-12-31 | 10 | USD |
FinancialAssets | 9,200,700,000 | 2025-12-31 | 4 | USD |
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | 7,332,559,000 | 2025-12-31 | 4 | USD |
CurrentAccruedExpensesAndOtherCurrentLiabilities | 7,332,559,000 | 2025-12-31 | 4 | USD |
CapitalReserve | 7,242,742,000 | 2025-12-31 | 4 | USD |
OperatingExpense | 7,139,603,000 | 2025-12-31 | 7 | USD |
AdjustmentsForReconcileProfitLoss | -6,930,447,000 | 2025-12-31 | 5 | USD |
EstimatedFinancialEffectOfContingentLiabilities | 6,620,537,000 | 2025-12-31 | 2 | USD |
TradeAndOtherCurrentPayablesToTradeSuppliers | 6,198,100,000 | 2025-12-31 | 4 | USD |
Inventories | 6,107,165,000 | 2025-12-31 | 4 | USD |
InventoriesTotal | 6,107,165,000 | 2025-12-31 | 2 | USD |
CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | 6,010,000,000 | 2025-12-31 | 2 | USD |
Goodwill | 5,852,575,000 | 2025-12-31 | 4 | USD |
IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets | 5,852,575,000 | 2025-12-31 | 8 | USD |
OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax | 5,115,942,000 | 2025-09-30 | 4 | USD |
SellingExpense | 4,988,727,000 | 2025-12-31 | 7 | USD |
CurrentTradeReceivables | 4,231,924,000 | 2025-12-31 | 4 | USD |
TradeReceivables | 4,231,924,000 | 2025-12-31 | 4 | USD |
ProfitLossFromOperatingActivities | 4,159,677,000 | 2025-12-31 | 7 | USD |
RestrictedCashAndCashEquivalents | 4,157,892,000 | 2025-09-30 | 2 | USD |
CashFlowsFromUsedInOperations | 4,045,785,000 | 2025-12-31 | 5 | USD |
RevenueFromContractsWithCustomers | 3,887,501,000 | 2025-12-31 | 4 | USD |
FinishedGoods | 3,859,259,000 | 2025-12-31 | 4 | USD |
OtherNoncurrentFinancialAssets | 3,609,199,000 | 2025-12-31 | 4 | USD |
LossesOnLitigationSettlements | 3,580,000,000 | 2025-12-31 | 2 | USD |
OtherCurrentReceivables | 3,563,852,000 | 2025-12-31 | 4 | USD |
OtherCashAndCashEquivalents | 3,558,215,000 | 2025-09-30 | 2 | USD |
ComprehensiveIncome | 3,155,165,000 | 2025-12-31 | 11 | USD |
ComprehensiveIncomeAttributableToOwnersOfParent | 3,091,844,000 | 2025-12-31 | 7 | USD |
RightofuseAssetsRevaluedAssetsAtCost | 3,040,030,000 | 2025-12-31 | 1 | USD |
ProfitLossBeforeTax | 2,620,298,000 | 2025-12-31 | 7 | USD |
Cash | 2,557,740,000 | 2025-12-31 | 4 | USD |
BiologicalAssets | 2,438,565,000 | 2025-12-31 | 2 | USD |
CashFlowsFromUsedInInvestingActivities | -2,311,364,000 | 2025-12-31 | 5 | USD |
AdjustmentsForDepreciationAndAmortisationExpense | 2,308,520,000 | 2025-12-31 | 5 | USD |
DepreciationExpense | 2,308,520,000 | 2025-12-31 | 7 | USD |
ProfitLoss | 2,229,792,000 | 2025-12-31 | 11 | USD |
GeneralAndAdministrativeExpense | 2,187,276,000 | 2025-12-31 | 7 | USD |
FinanceCosts | 2,121,483,000 | 2025-12-31 | 7 | USD |
ProfitLossAttributableToOwnersOfParent | 2,024,333,000 | 2025-12-31 | 7 | USD |
ReceivablesFromTaxesOtherThanIncomeTax | 1,970,000,000 | 2025-12-31 | 2 | USD |
CashOnHand | 1,962,794,000 | 2025-09-30 | 2 | USD |
CurrentBiologicalAssets | 1,826,766,000 | 2025-12-31 | 8 | USD |
IntangibleAssetsOtherThanGoodwill | 1,825,592,000 | 2025-12-31 | 8 | USD |
IssueOfEquity | 1,808,187,000 | 2025-12-31 | 2 | USD |
CashFlowsFromUsedInFinancingActivities | -1,771,925,000 | 2025-12-31 | 5 | USD |
LeaseLiabilities | 1,767,285,000 | 2025-12-31 | 8 | USD |
GrossLeaseLiabilities | 1,733,146,000 | 2025-12-31 | 2 | USD |
RetainedEarnings | 1,670,631,000 | 2025-09-30 | 1 | USD |
RightofuseAssets | 1,613,647,000 | 2025-12-31 | 8 | USD |
DividendsPaidClassifiedAsFinancingActivities | 1,573,855,000 | 2025-12-31 | 4 | USD |
CurrentProvisionsForEmployeeBenefits | 1,560,159,000 | 2025-12-31 | 4 | USD |
AdjustmentsForFinanceCosts | 1,556,277,000 | 2025-12-31 | 5 | USD |
FinanceIncomeCost | -1,556,276,000 | 2025-12-31 | 7 | USD |
OtherFinanceIncome | 1,556,276,000 | 2025-12-31 | 3 | USD |
NoncurrentDividendPayables | 1,500,000,000 | 2025-04-17 | 1 | USD |
FinancialLiabilitiesAtAmortisedCost | 1,488,196,000 | 2025-12-31 | 3 | USD |
NoncurrentLeaseLiabilities | 1,412,398,000 | 2025-12-31 | 4 | USD |
InterestPaidClassifiedAsOperatingActivities | 1,302,194,000 | 2025-12-31 | 5 | USD |
InterestExpenseOnBorrowings | 1,220,844,000 | 2025-12-31 | 5 | USD |
DeferredTaxLiabilities | 1,169,300,000 | 2025-12-31 | 4 | USD |
NumberOfSharesOutstanding | 1,109,058,185 | 2025-12-31 | 1 | shares |
WeightedAverageShares | 1,068,508,877 | 2025-12-31 | 7 | shares |
IncreaseDecreaseInCashAndCashEquivalents | -1,048,536,000 | 2025-12-31 | 5 | USD |
RawMaterials | 1,015,266,000 | 2025-12-31 | 4 | USD |
CommercialPapersIssued | 1,000,000,000 | 2025-12-22 | 1 | USD |
GainsLossesOnExchangeDifferencesOnTranslationNetOfTax | 931,725,000 | 2025-12-31 | 7 | USD |
OtherComprehensiveIncome | 925,373,000 | 2025-12-31 | 7 | USD |
FinancialLiabilitiesAtFairValue | -922,938,000 | 2025-12-31 | 4 | USD |
OtherFinancialLiabilities | 848,716,000 | 2025-12-31 | 2 | USD |
ShorttermBorrowings | 833,085,000 | 2025-12-31 | 4 | USD |
AdjustmentsForDecreaseIncreaseInBiologicalAssets | -820,628,000 | 2025-12-31 | 5 | USD |
NoncontrollingInterests | 819,211,000 | 2025-12-31 | 4 | USD |
IncomeTaxesPaidRefundClassifiedAsOperatingActivities | 808,962,000 | 2025-12-31 | 5 | USD |
FinancialAssetsAtFairValueThroughProfitOrLoss | 805,029,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment | 799,773,000 | 2025-12-31 | 5 | USD |
AdjustmentsForDecreaseIncreaseInInventories | -793,653,000 | 2025-12-31 | 5 | USD |
Provisions | 759,000,000 | 2024-12-31 | 1 | USD |
OtherCurrentLiabilities | 704,509,000 | 2025-12-31 | 4 | USD |
ProductionSupplies | 686,167,000 | 2025-12-31 | 4 | USD |
NotionalAmount | 672,843,000 | 2025-12-31 | 4 | USD |
OtherNoncurrentReceivables | 668,072,000 | 2025-12-31 | 4 | USD |
ProvisionUsedOtherProvisions | 632,339,000 | 2025-12-31 | 2 | USD |
AdjustmentsForCurrentTaxOfPriorPeriod | 632,000,000 | 2025-12-31 | 2 | USD |
DeferredTaxLiabilityAsset | 622,286,000 | 2025-12-31 | 4 | USD |
AdjustmentsForIncreaseDecreaseInTradeAccountPayable | 612,566,000 | 2025-12-31 | 5 | USD |
NoncurrentBiologicalAssets | 611,799,000 | 2025-12-31 | 8 | USD |
InvestmentFundsAmountContributedToFairValueOfPlanAssets | 600,000,000 | 2025-08-13 | 1 | USD |
SaleOrIssueOfTreasuryShares | 600,000,000 | 2025-12-31 | 1 | USD |
TreasuryShares | 598,423,000 | 2025-12-31 | 1 | USD |
FinanceIncome | 565,207,000 | 2025-12-31 | 7 | USD |
DeferredTaxAssets | 547,014,000 | 2025-12-31 | 5 | USD |
WorkInProgress | 546,473,000 | 2025-12-31 | 4 | USD |
AdjustmentsForDividendIncome | 500,000,000 | 2025-09-30 | 3 | USD |
OtherNoncurrentAssets | 488,803,000 | 2025-12-31 | 4 | USD |
CurrentInvestments | 454,781,000 | 2025-12-31 | 4 | USD |
ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax | 451,293,000 | 2025-05-23 | 5 | USD |
CurrentTaxExpenseIncome | 450,240,000 | 2025-12-31 | 7 | USD |
OtherCurrentFinancialLiabilities | 440,989,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseThroughNetExchangeDifferencesGoodwill | 433,460,000 | 2025-12-31 | 5 | USD |
OtherCurrentAssets | 433,372,000 | 2025-12-31 | 4 | USD |
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | 432,516,000 | 2025-12-31 | 5 | USD |
UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable | 432,516,000 | 2025-12-31 | 3 | USD |
DividendsRecognisedAsDistributionsToOwnersOfParent | 420,500,000 | 2025-09-30 | 1 | USD |
RevenueFromInterest | 417,197,000 | 2025-12-31 | 7 | USD |
CurrentTaxLiabilitiesNoncurrent | 407,727,000 | 2025-12-31 | 4 | USD |
NoncurrentFinancialLiabilities | 407,727,000 | 2025-12-31 | 4 | USD |
TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense | 403,460,000 | 2025-12-31 | 2 | USD |
IncomeTaxExpenseContinuingOperations | 390,506,000 | 2025-12-31 | 7 | USD |
AdjustmentsForIncomeTaxExpense | 390,505,000 | 2025-12-31 | 5 | USD |
EstimatedFinancialEffectOfContingentAssets | 368,575,000 | 2025-12-31 | 4 | USD |
ReserveOfChangeInValueOfTimeValueOfOptions | 362,500,000 | 2025-08-13 | 2 | USD |
IncreaseDecreaseThroughAcquisitionOfSubsidiary | -362,463,000 | 2025-09-30 | 2 | USD |
PaymentsForShareIssueCosts | 362,463,000 | 2025-09-30 | 2 | USD |
IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions | -360,218,000 | 2025-09-30 | 2 | USD |
CurrentDividendPayables | 358,621,000 | 2024-12-31 | 1 | USD |
DividendsPaidToNoncontrollingInterests | 356,158,000 | 2025-12-31 | 7 | USD |
DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities | 355,682,000 | 2025-09-30 | 2 | USD |
CurrentLeaseLiabilities | 354,887,000 | 2025-12-31 | 4 | USD |
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | -347,327,000 | 2025-12-31 | 5 | USD |
CurrentContractLiabilities | 344,423,000 | 2025-12-31 | 4 | USD |
UndiscountedOperatingLeasePaymentsToBeReceived | 320,748,000 | 2025-12-31 | 2 | USD |
NoncurrentProvisionsForEmployeeBenefits | 288,065,000 | 2025-12-31 | 4 | USD |
CurrentTaxLiabilitiesCurrent | 288,030,000 | 2025-12-31 | 4 | USD |
DerivativeFinancialLiabilities | -267,214,000 | 2025-12-31 | 4 | USD |
IncomeFromFinesAndPenalties | 230,000,000 | 2025-12-31 | 1 | USD |
GainsLossesOnChangeInFairValueOfDerivatives | -217,427,000 | 2025-12-31 | 7 | USD |
OtherLongtermProvisions | 209,358,000 | 2025-12-31 | 4 | USD |
ProfitLossAttributableToNoncontrollingInterests | 205,459,000 | 2025-12-31 | 7 | USD |
DividendsReceived | 200,000,000 | 2025-10-30 | 1 | USD |
IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities | -199,815,000 | 2025-12-31 | 3 | USD |
AdjustmentsForIncreaseDecreaseInOtherLiabilities | -198,577,000 | 2025-12-31 | 5 | USD |
SharePremium | 193,572,000 | 2025-06-15 | 6 | USD |
Borrowings | 190,998,000 | 2025-12-31 | 2 | USD |
AdjustmentsForProvisions | 189,362,000 | 2025-12-31 | 5 | USD |
InterestReceivedClassifiedAsOperatingActivities | 188,362,000 | 2025-12-31 | 5 | USD |
OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities | 185,675,000 | 2025-12-31 | 2 | USD |
InterestRevenueExpense | 182,275,000 | 2025-12-31 | 7 | USD |
InvestmentAccountedForUsingEquityMethod | 171,612,000 | 2025-12-31 | 8 | USD |
InterestIncomeOnDeposits | 169,330,000 | 2025-12-31 | 5 | USD |
OtherProvisions | 164,408,000 | 2025-09-30 | 4 | USD |
InventoriesPledgedAsSecurityForLiabilities | 159,562,000 | 2025-12-31 | 4 | USD |
OtherShorttermProvisions | 159,217,000 | 2025-12-31 | 4 | USD |
CurrentDerivativeFinancialLiabilities | 156,405,000 | 2025-12-31 | 4 | USD |
BankAndSimilarCharges | 155,860,000 | 2025-12-31 | 7 | USD |
NoncurrentDerivativeFinancialAssets | 155,602,000 | 2025-12-31 | 4 | USD |
DerivativeFinancialAssets | 155,441,000 | 2025-12-31 | 4 | USD |
OtherCurrentPayables | 152,959,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill | 130,097,000 | 2025-12-31 | 5 | USD |
GainsLossesOnHedgesOfNetInvestmentsInForeignOperationsNetOfTax | 126,386,000 | 2025-05-23 | 5 | USD |
AdjustmentsForDecreaseIncreaseInOtherCurrentAssets | -123,592,000 | 2025-12-31 | 5 | USD |
PurchasesOfGoodsRelatedPartyTransactions | 123,446,000 | 2025-12-31 | 2 | USD |
AdjustmentsForGainsLossesOnDisposalOfFinancialAssets | 117,062,000 | 2025-12-31 | 2 | USD |
ContractualCapitalCommitments | 115,804,000 | 2025-12-31 | 4 | USD |
AmortisationIntangibleAssetsOtherThanGoodwill | 114,829,000 | 2025-12-31 | 5 | USD |
OtherAdjustmentsForNoncashItems | 114,717,000 | 2025-12-31 | 3 | USD |
NoncurrentDerivativeFinancialLiabilities | 114,376,000 | 2025-12-31 | 4 | USD |
OtherIncome | 111,929,000 | 2025-12-31 | 7 | USD |
EffectOfExchangeRateChangesOnCashAndCashEquivalents | 102,799,000 | 2025-12-31 | 5 | USD |
DividendsPaid | 96,573,000 | 2025-12-31 | 6 | USD |
NumberOfSharesIssued | 94,537,534 | 2025-12-31 | 1 | shares |
Accruals | 88,200,000 | 2025-12-31 | 2 | USD |
UndiscountedExpectedCreditLossesAtInitialRecognitionOnPurchasedOrOriginatedCreditimpairedFinancialAssetsInitiallyRecognised | 76,685,000 | 2025-12-31 | 4 | USD |
ImpairmentLoss | 76,685,000 | 2025-12-31 | 1 | USD |
TaxEffectOfForeignTaxRates | 75,755,000 | 2025-12-31 | 7 | USD |
OtherExpenseByNature | 75,529,000 | 2025-12-31 | 7 | USD |
DisposalsPropertyPlantAndEquipment | 73,846,000 | 2025-12-31 | 5 | USD |
ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | 73,200,000 | 2025-12-31 | 5 | USD |
AccumulatedOtherComprehensiveIncome | 73,048,000 | 2025-09-30 | 2 | USD |
InvestmentIncome | 70,797,000 | 2025-12-31 | 5 | USD |
IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets | 68,164,000 | 2023-12-31 | 1 | USD |
ComprehensiveIncomeAttributableToNoncontrollingInterests | 63,321,000 | 2025-12-31 | 7 | USD |
DeferredTaxExpenseIncome | -59,734,000 | 2025-12-31 | 7 | USD |
CurrentAssetsRecognisedAsOfAcquisitionDate | 50,000,000 | 2025-12-31 | 2 | USD |
OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities | -45,831,000 | 2025-12-31 | 2 | USD |
NoncurrentFinancialAssets | 45,780,000 | 2025-12-31 | 2 | USD |
CurrentValueAddedTaxPayables | 45,662,000 | 2025-12-31 | 4 | USD |
ShareIssueRelatedCost | 43,200,000 | 2025-12-31 | 1 | USD |
OtherNoncurrentLiabilities | 42,180,000 | 2025-12-31 | 4 | USD |
AmountsReceivableRelatedPartyTransactions | 41,231,000 | 2025-12-31 | 3 | USD |
NoncurrentReceivablesDueFromRelatedParties | 41,231,000 | 2025-12-31 | 3 | USD |
OtherOperatingIncomeExpense | 41,161,000 | 2025-12-31 | 7 | USD |
OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities | -39,274,000 | 2025-12-31 | 2 | USD |
IncreaseDecreaseThroughTransfersAndOtherChangesEquity | -37,693,000 | 2025-12-31 | 7 | USD |
OtherReserves | -37,470,000 | 2024-12-31 | 1 | USD |
IssuedCapital | 35,114,000 | 2025-12-31 | 5 | USD |
IssuedCapitalOrdinaryShares | 35,114,000 | 2025-12-31 | 3 | USD |
IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment | 35,033,000 | 2025-12-31 | 4 | USD |
AdjustmentsForFairValueGainsLosses | -31,732,000 | 2025-12-31 | 5 | USD |
ExpenseOfRestructuringActivities | 31,354,000 | 2025-12-31 | 4 | USD |
CostOfPurchasedEnergySold | 29,422,000 | 2025-09-30 | 2 | USD |
ActualClaimsThatAriseFromContractsWithinScopeOfIFRS17 | 29,000,000 | 2021-12-31 | 1 | USD |
KeyManagementPersonnelCompensation | 26,021,000 | 2025-12-31 | 5 | USD |
TaxExpenseOtherThanIncomeTaxExpense | 25,900,000 | 2009-12-31 | 1 | USD |
IncreaseThroughBusinessCombinationsContractAssets | 24,542,000 | 2023-12-31 | 1 | USD |
ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | 22,148,000 | 2025-12-31 | 2 | USD |
AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets | -19,557,000 | 2025-12-31 | 5 | USD |
GainsLossesOnFairValueAdjustmentBiologicalAssets | 19,148,000 | 2025-12-31 | 5 | USD |
IncreaseDecreaseThroughChangeInEquityOfSubsidiaries | -18,628,000 | 2025-12-31 | 2 | USD |
CostOfInventoriesRecognisedAsExpenseDuringPeriod | 18,160,000 | 2025-12-31 | 4 | USD |
ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod | 16,897,000 | 2025-12-31 | 7 | USD |
OtherLiabilities | 16,300,000 | 2025-12-31 | 3 | USD |
IncomeTaxesPaidRefund | 14,842,000 | 2025-12-31 | 3 | USD |
AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | 13,833,000 | 2025-12-31 | 5 | USD |
DividendsRecognisedAsDistributionsToNoncontrollingInterests | 13,324,000 | 2024-12-31 | 1 | USD |
OtherReceivables | 13,271,000 | 2025-12-31 | 4 | USD |
NetDeferredTaxAssets | 12,805,000 | 2025-12-31 | 4 | USD |
AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss | 12,767,000 | 2025-12-31 | 5 | USD |
OtherFinancialAssets | 10,220,000 | 2024-12-31 | 1 | USD |
IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions | 9,370,000 | 2025-09-30 | 2 | USD |
IncreaseDecreaseThroughSharebasedPaymentTransactions | 9,255,000 | 2025-12-31 | 7 | USD |
GainsLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax | -8,431,000 | 2025-12-31 | 7 | USD |
GainsLossesOnCashFlowHedgesNetOfTax | -7,305,000 | 2025-12-31 | 7 | USD |
DividendsReceivedClassifiedAsInvestingActivities | 7,268,000 | 2025-12-31 | 5 | USD |
KeyManagementPersonnelCompensationSharebasedPayment | 7,217,000 | 2023-12-31 | 1 | USD |
PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities | 7,125,000 | 2025-12-31 | 5 | USD |
WagesAndSalaries | 6,779,000 | 2025-12-31 | 5 | USD |
DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions | 6,119,000 | 2025-09-30 | 1 | USD |
RentalIncome | 5,902,000 | 2025-12-31 | 1 | USD |
IncreaseDecreaseThroughForeignExchangeFinancialAssets | -5,379,000 | 2025-12-31 | 5 | USD |
DeferredTaxExpenseIncomeRecognisedInProfitOrLoss | 3,841,000 | 2025-12-31 | 2 | USD |
InterestCostsIncurred | 2,889,000 | 2025-12-31 | 5 | USD |
InsuranceRevenueAllocationOfPortionOfPremiumsThatRelateToRecoveryOfInsuranceAcquisitionCashFlows | 2,792,000 | 2025-12-31 | 5 | USD |
AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill | 2,131,000 | 2025-12-31 | 2 | USD |
GovernmentGrants | 2,093,000 | 2025-12-31 | 1 | USD |
DonationsAndSubsidiesExpense | 1,806,000 | 2025-12-31 | 7 | USD |
DerivativeFinancialAssetsHeldForHedging | -1,644,000 | 2025-12-31 | 2 | USD |
OtherComprehensiveIncomeBeforeTaxCashFlowHedges | 1,479,000 | 2025-12-31 | 2 | USD |
PaymentsFromChangesInOwnershipInterestsInSubsidiaries | 1,294,000 | 2025-12-31 | 2 | USD |
GainsLossesOnCashFlowHedgesBeforeTax | 1,293,000 | 2025-12-31 | 2 | USD |
OtherComprehensiveIncomeBeforeTaxHedgesOfNetInvestmentsInForeignOperations | 1,293,000 | 2025-12-31 | 2 | USD |
CancellationOfTreasuryShares | -1,263,000 | 2025-09-30 | 1 | USD |
GainsLossesOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeilingExcludingInterestIncomeOrExpenseNetOfTaxDefinedBenefitPlans | 1,206,000 | 2025-12-31 | 7 | USD |
AcquisitionsThroughBusinessCombinationsRightofuseAssets | 1,179,000 | 2025-12-31 | 3 | USD |
OtherComprehensiveIncomeNetOfTaxCashFlowHedges | 977,000 | 2025-12-31 | 4 | USD |
OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | 865,000 | 2025-12-31 | 7 | USD |
IncomeTaxRelatingToExchangeDifferencesOnTranslationOfForeignOperationsAndHedgesOfNetInvestmentsInForeignOperationsIncludedInOtherComprehensiveIncome | 502,000 | 2025-12-31 | 2 | USD |
ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment | 493,000 | 2025-12-31 | 4 | USD |
IncreaseDecreaseThroughTransfersAndOtherChangesGoodwill | 258,000 | 2025-12-31 | 2 | USD |
IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome | 169,000 | 2025-12-31 | 7 | USD |
DividendPayables | 165,000 | 2025-09-30 | 8 | USD |
CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome | 161,000 | 2025-12-31 | 2 | USD |
CurrentDerivativeFinancialAssets | 153,000 | 2024-12-31 | 2 | USD |
OtherComprehensiveIncomeAttributableToNoncontrollingInterests | 83,000 | 2025-09-30 | 2 | USD |
DepreciationRatePropertyPlantAndEquipment | 11,633 | 2025-12-31 | 5 | pure |
RevenueFromDividends | 5,000 | 2024-12-31 | 1 | USD |
DividendsPaidOrdinarySharesPerShare | 2 | 2025-07-30 | 3 | USD/shares |
BasicEarningsLossPerShare | 2 | 2025-12-31 | 7 | USD/shares |
DilutedEarningsLossPerShare | 2 | 2025-12-31 | 7 | USD/shares |
PercentageOfVotingEquityInterestsAcquired | 1 | 2025-12-10 | 6 | pure |
InvestmentFundsPercentageContributedToFairValueOfPlanAssets | 1 | 2025-07-07 | 1 | pure |
ProportionOfVotingRightsHeldByNoncontrollingInterests | 1 | 2025-12-31 | 4 | pure |
ExpectedDividendAsPercentageShareOptionsGranted | 0 | 2025-01-27 | 2 | pure |
TaxRateEffectOfForeignTaxRates | 0 | 2025-12-31 | 2 | pure |
TaxRateEffectOfTaxLosses | 0 | 2025-12-31 | 1 | pure |
ProportionOfOwnershipInterestsHeldByNoncontrollingInterests | 0 | 2025-12-31 | 4 | pure |
AverageEffectiveTaxRate | 0 | 2025-12-31 | 1 | pure |
PercentageOfEntitysRevenue | 0 | 2025-09-30 | 1 | pure |
ProportionOfOwnershipInterestInAssociate | 0 | 2025-12-31 | 2 | pure |
What to be careful about
What this model itself distrusts about JBS's figures. Written by the derivation as it ran, not added afterwards.
- revenue is annual, not TTM
- operating income is annual, not TTM
- forward EPS growth +81.9% is analyst consensus, not a filing: consensus 2027 EPS 6.65 against trailing 2.01, over 2 year(s), from 7 analysts (taken 2026-10-11)
- durability rests on 3 of 4 inputs; not tagged: worst year
- growth rests on 3 of 4 inputs; not tagged: sustained growth